Immunome's experimental drug meets main goal in late-stage study [Yahoo! Finance]
Immunome, Inc. (IMNM)
Company Research
Source: Yahoo! Finance
The oral drug, varegacestat, is ?being tested ?in patients with desmoid tumors, also known ?as aggressive fibromatosis or desmoid-type fibromatosis, that are aggressive non-metastatic ?soft tissue tumors that ?are prone to recurrence. The trial showed varegacestat significantly improved progression-free survival compared with placebo, cutting the risk ?of disease progression ?or death ?by 84%. Immunome plans to file for U.S. approval ?in the ?second quarter of 2026. Shares of cancer drug developer ?were up 30% in premarket ?trading. (Reporting by Siddhi Mahatole ?in Bengaluru)
Show less
Read more
Impact Snapshot
Event Time:
IMNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNM alerts
High impacting Immunome, Inc. news events
Weekly update
A roundup of the hottest topics
IMNM
News
- Why Immunome Stock Surged Today [Yahoo! Finance]Yahoo! Finance
- Immunome (NASDAQ:IMNM) was given a new $40.00 price target on by analysts at Leerink Partners.MarketBeat
- Immunome Announces Proposed Public Offering of Common Stock [Yahoo! Finance]Yahoo! Finance
- Immunome Announces Proposed Public Offering of Common StockBusiness Wire
- Stocks making the biggest moves midday: Zillow, KLA, iRobot, Immunome & more [CNBC]CNBC
IMNM
Earnings
- 8/6/25 - Beat
IMNM
Sec Filings
- 12/15/25 - Form 424B5
- 12/15/25 - Form 8-K
- 11/7/25 - Form SCHEDULE
- IMNM's page on the SEC website